These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 36048712)
1. Specific binding of Hsp27 and phosphorylated Tau mitigates abnormal Tau aggregation-induced pathology. Zhang S; Zhu Y; Lu J; Liu Z; Lobato AG; Zeng W; Liu J; Qiang J; Zeng S; Zhang Y; Liu C; Liu J; He Z; Zhai RG; Li D Elife; 2022 Sep; 11():. PubMed ID: 36048712 [TBL] [Abstract][Full Text] [Related]
2. Nicotinamide mononucleotide adenylyltransferase uses its NAD Ma X; Zhu Y; Lu J; Xie J; Li C; Shin WS; Qiang J; Liu J; Dou S; Xiao Y; Wang C; Jia C; Long H; Yang J; Fang Y; Jiang L; Zhang Y; Zhang S; Zhai RG; Liu C; Li D Elife; 2020 Apr; 9():. PubMed ID: 32250733 [TBL] [Abstract][Full Text] [Related]
3. Small heat shock proteins Hsp27 or alphaB-crystallin and the protein components of neurofibrillary tangles: tau and neurofilaments. Björkdahl C; Sjögren MJ; Zhou X; Concha H; Avila J; Winblad B; Pei JJ J Neurosci Res; 2008 May; 86(6):1343-52. PubMed ID: 18061943 [TBL] [Abstract][Full Text] [Related]
5. Hsp90 regulates tau pathology through co-chaperone complexes in Alzheimer's disease. Salminen A; Ojala J; Kaarniranta K; Hiltunen M; Soininen H Prog Neurobiol; 2011 Jan; 93(1):99-110. PubMed ID: 21056617 [TBL] [Abstract][Full Text] [Related]
6. Cellular factors modulating the mechanism of tau protein aggregation. Fontaine SN; Sabbagh JJ; Baker J; Martinez-Licha CR; Darling A; Dickey CA Cell Mol Life Sci; 2015 May; 72(10):1863-79. PubMed ID: 25666877 [TBL] [Abstract][Full Text] [Related]
7. Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer's disease and other tauopathies. Xia Y; Prokop S; Gorion KM; Kim JD; Sorrentino ZA; Bell BM; Manaois AN; Chakrabarty P; Davies P; Giasson BI Acta Neuropathol Commun; 2020 Jun; 8(1):88. PubMed ID: 32571418 [TBL] [Abstract][Full Text] [Related]
8. Release of a disordered domain enhances HspB1 chaperone activity toward tau. Baughman HER; Pham TT; Adams CS; Nath A; Klevit RE Proc Natl Acad Sci U S A; 2020 Feb; 117(6):2923-2929. PubMed ID: 31974309 [TBL] [Abstract][Full Text] [Related]
9. Microglial activation arises after aggregation of phosphorylated-tau in a neuron-specific P301S tauopathy mouse model. van Olst L; Verhaege D; Franssen M; Kamermans A; Roucourt B; Carmans S; Ytebrouck E; van der Pol SMA; Wever D; Popovic M; Vandenbroucke RE; Sobrino T; Schouten M; de Vries HE Neurobiol Aging; 2020 May; 89():89-98. PubMed ID: 32008854 [TBL] [Abstract][Full Text] [Related]
10. αB-crystallin and HSP27 in glial cells in tauopathies. López-González I; Carmona M; Arregui L; Kovacs GG; Ferrer I Neuropathology; 2014 Dec; 34(6):517-26. PubMed ID: 24985029 [TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of the overlooked tyrosine 310 regulates the structure, aggregation, and microtubule- and lipid-binding properties of Tau. Ait-Bouziad N; Chiki A; Limorenko G; Xiao S; Eliezer D; Lashuel HA J Biol Chem; 2020 Jun; 295(23):7905-7922. PubMed ID: 32341125 [TBL] [Abstract][Full Text] [Related]
12. Nuclear and cellular, micro and nano calcification in Alzheimer's disease patients and correlation to phosphorylated Tau. Tsolaki E; Csincsik L; Xue J; Lengyel I; Bertazzo S Acta Biomater; 2022 Apr; 143():138-144. PubMed ID: 35259518 [TBL] [Abstract][Full Text] [Related]
13. Circuitry and Synaptic Dysfunction in Alzheimer's Disease: A New Tau Hypothesis. Mondragón-Rodríguez S; Salgado-Burgos H; Peña-Ortega F Neural Plast; 2020; 2020():2960343. PubMed ID: 32952546 [TBL] [Abstract][Full Text] [Related]
14. Application of deep learning to understand resilience to Alzheimer's disease pathology. Lee CS; Latimer CS; Henriksen JC; Blazes M; Larson EB; Crane PK; Keene CD; Lee AY Brain Pathol; 2021 Nov; 31(6):e12974. PubMed ID: 34009663 [TBL] [Abstract][Full Text] [Related]
15. Hsp90 co-chaperones, FKBP52 and Aha1, promote tau pathogenesis in aged wild-type mice. Criado-Marrero M; Gebru NT; Blazier DM; Gould LA; Baker JD; Beaulieu-Abdelahad D; Blair LJ Acta Neuropathol Commun; 2021 Apr; 9(1):65. PubMed ID: 33832539 [TBL] [Abstract][Full Text] [Related]
16. HspB1 and Hsc70 chaperones engage distinct tau species and have different inhibitory effects on amyloid formation. Baughman HER; Clouser AF; Klevit RE; Nath A J Biol Chem; 2018 Feb; 293(8):2687-2700. PubMed ID: 29298892 [TBL] [Abstract][Full Text] [Related]
17. Molecular chaperone-mediated tau protein metabolism counteracts the formation of granular tau oligomers in human brain. Sahara N; Maeda S; Yoshiike Y; Mizoroki T; Yamashita S; Murayama M; Park JM; Saito Y; Murayama S; Takashima A J Neurosci Res; 2007 Nov; 85(14):3098-108. PubMed ID: 17628496 [TBL] [Abstract][Full Text] [Related]